Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Clinical Research|January 1, 1981
Metoprolol in high renin hypertension. A comparison with propranololL D Lameyer, C J Hesse
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Rejection prophylaxis with sequential OKT3 and CSA after kidney transplantationW Weimar, C J Hesse, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1993
Single-shot, high-dose rabbit ATG for rejection prophylaxis after kidney transplantationR Zietse, E P van Steenberge, C J Hesse, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
In vitro and in vivo effects of BT 563, an anti-interleukin-2 receptor monoclonal antibodyT Van Gelder, C R Daane, L M Vaessen, et al.
Therapeutic Drug Monitoring|November 1, 1990
Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipientsC J Hesse, C C Baan, R Daane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional studyP J Smak Gregoor, T van Gelder, C J Hesse, et al.
Clinical Nephrology|March 11, 2000
TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failureI C van Riemsdijk-van Overbeeke, C C Baan, C J Hesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipientsT van Gelder, A H Mulder, A H Balk, et al.
Pageof 2